4-(1H-IMIDAZOL-5-YL)-1H-PYRROLO [2,3-B] PYRIDINES FOR USE IN THE TREATMENT OF LEUKAEMIAS, LYMPHOMAS AND SOLID TUMORS

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Science. Official publication website can be found on muni.cz.

Authors	BRYJA Vítězslav JANOVSKÁ Pavlína GREGOROVÁ Michaela NĚMEC Václav KHIRSARIYA PrashantKumar PARUCH Kamil
Year of publication	2023
Type	Patent
MU Faculty or unit	Faculty of Science
Publisher	China National Intellectual Property Administration
State	China
Patent's number	CN111936496
web	https://worldwide.espacenet.com/patent/search/family/061837684/publication/CN111936496B?q=pn%3DCN111936496B
Description	The present invention relates to novel 4-(1H-imidazol-5-yl)-1H-pyrrolo[2,3-b]pyridine compounds which are useful in the treatment of lymphomas, leukaemias, and solid tumors.
Related projects:	Preclinical Progression of New Organic Compounds with Targeted Biological Activity CZ-OPENSCREEN: National Infrastructure for Chemical Biology